The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance
Sirima SB, Konate A, Tiono AB, Convelbo N, Cousens S, Pagnoni F. 2003. Early treatment of childhood fevers with pre-packaged antimalarial drugs in the home reduces severe malaria morbidity in Burkina Faso. Tropical Medicine and International Health 8(2):133-139.
Snow RW, Craig M, Deichmann U, Marsh K. 1999. Estimating mortality, morbidity and disability due to malaria among Africa’s non-pregnant population. Bulletin of the World Health Organization 77(8):624-640.
Sternberg RJ, Nokes K, Geissler PW. 2000. The relationship between academic and practical intelligence: A case study in Kenya. Intelligence 29:401-418.
Taylor RB, Shakoor O, Behrens RH, Everard M, Low AS, Wangboonskul J, Reid RG, Kolawole JA. 2001. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet 357(9272):1933-1936.
TDR/RBM. 2002. Scaling up home management of malaria. TDR News 67.
Thera MA, D’Alessandro U, Thiero M, Ouedraogo A, Packou J, Souleymane OA, Fane M, Ade G, Alvez F, Doumbo O. 2000. Child malaria treatment practices among mothers in the district of Yanfolila, Sikasso region, Mali. Tropical Medicine and International Health 5(12):876-881.
Trape JF, Zoulani A, Quinet MC. 1987. Assessment of the incidence and prevalence of clinical malaria in semi-immune children exposed to intense and perennial transmission. American Journal of Epidemiology 126(2):193-201.
Trape JF, Lefebvre-Zante E, Legros F, Druilhe P, Rogier C, Bouganali H, Salem G. 1993. Malaria morbidity among children exposed to low seasonal transmission in Dakar, Senegal and its implications for malaria control in tropical Africa . American Journal of Tropical Medicine and Hygiene 48(6):748-756.
van der Geest S, Geissler PW. 2003. Editorial: Should medicines be kept away from children? African considerations. Tropical Medicine and International Health 8(2):97-99.
von Seidlein L, Clarke S, Alexander N, Manneh F, Doherty T, Pinder M, Walraven G, Greenwood B. 2002. Treatment uptake by individuals infected with Plasmodium falciparum in rural Gambia, West Africa. Bulletin of the World Health Organization 80(10):790-796.
Wan Po AL. 2001. Too much, too little, or none at all: Dealing with substandard and fake drugs. Lancet 357(9272):1904.
WHO. 2000. Severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 94(Suppl 1):S1-S90.
WHO. 2002. Strategic Framework for Malaria Control During Pregnancy in the WHO Africa Region. Geneva: World Health Organization.
WHO. 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. Geneva: World Health Organization. WHO/HTM/ RBM/2003.50 .
WHO/UNICEF. 2003. The Africa Malaria Report 2003. Geneva: World Health Organization.
Wondemagegnehu E. 1995. Counterfeit and Substandard Drugs in Myanmar and Viet Nam. Geneva: World Health Organization.
Yeboah-Antwi K, Gyapong JO, Asare IK, Barnish G, Evans DB, Adjei S. 2001. Impact of prepackaging antimalarial drugs on cost to patients and compliance with treatment. Bulletin of the World Health Organization 79(5):394-399.
Yepez MC, Zambrano D, Carrasco F, Yepez RF. 2000. [The factors associated with noncompliance with antimalarial treatment in Ecuadorian patients]. [Spanish]. Revista Cubana de Medicina Tropical 52(2):81-89.